Search
10 results for “capital increase”

Bradesco Announces R$10 Billion Capital Raise Paired With Accelerated JCP Payout
Bradesco is launching a capital increase up to R$10 billion, structuring the move to allow shareholders to use an accelerated JCP payment to subscribe at a discount.

Bradesco Offers Shareholders Discounted Shares, JCP Offset to Avoid Dilution in R$10 Billion Capital Increase
Brazilian bank Bradesco is offering existing shareholders the chance to subscribe to new shares at a 6% discount, utilizing R$6.5B in advanced JCP payments to avoid dilution.

Light S.A. (LIGT3) Soars on Final Technical Step to Exit Judicial Recovery
Brazilian utility Light S.A. stock was the B3's top small-cap gainer as a key technical step in its R$1.5 billion restructuring concludes.

Light (LIGT3) Approves R$1.35 Billion Capital Increase to Accelerate Judicial Recovery Exit
Brazil utility Light S.A. approved a R$1.35 billion capital injection, clearing the path for its formal request to exit judicial recovery (RJ).

Suno Snaps Up 4.6% Gafisa Stake Ahead of Key Shareholder Vote
Suno Asset Management has acquired a 4.6% stake in troubled homebuilder Gafisa (GFSA3) ahead of a crucial July 16 extraordinary general meeting.

Itaúsa Backs Aegea Capital Increase to Tackle Leverage
Holding company Itaúsa commits up to R$ 1.5 billion to support a planned capital increase by sanitation giant Aegea, reinforcing liquidity and capital discipline.

Viveo Approves R$ 870 Million Capital Increase to Delever
CM Hospitalar (Viveo) approved a capital increase of up to R$ 869.8 million at a deep discount, anchored by the Bueno family's debt conversion.

Viveo launches R$ 870m capital raise to slash leverage
Viveo (VVEO3) announced a capital increase of up to R$ 870 million anchored by DNA Capital (Bueno family) to aggressively de-lever its balance sheet.

Viveo Capital Increase: R$ 870 Million Plan to Cut Leverage
Brazilian healthcare distributor Viveo (VVEO3) launches a capital increase of up to R$ 869.76 million to reduce debt and optimize its capital structure.

Viveo Launches R$ 870M Capital Increase to Tackle Debt
Brazilian healthcare distributor Viveo (VVEO3) has approved a private capital increase of up to R$ 869.76 million to reduce leverage and restructure debt.